
Cialis maker Eli Lilly and French drug maker Sanofi agreed to a licensing deal allowing Sanofi to sell an over-the-counter version of the prescription erectile dysfunction drug if regulars approve.
Eli Lilly and Sanofi officials said an over-the-counter Cialis could provide easier treatment for men with erectile dysfunction and help reduce the illicit Internet sale of bogus or stolen Cialis. The prescription erectile dysfunction drug Cialis made about $2.2 billion in global sales last year, which surpassed Viagra's sales of $1.9 billion, the Wall Street Journal reported.
However, it's uncertain if U.S. regulators would approve the sale of an erectile dysfunction drug without a doctor's guidance because the drug can have several side effects including a sudden drop in blood pressure if taken with some heart and blood-pressure medications, and causing fainting or even death, among other adverse outcomes.
In addition, the need for erectile dysfunction drugs provide a red flag that patients could have other medical conditions such as diabetes and coronary artery disease. If men were able to buy impotence drugs without visiting a doctor, these conditions might be missed, he said.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor